178 related articles for article (PubMed ID: 30106307)
21. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
22. Discovery of cyclooxygenase-2 inhibitors from Kadsura coccinea by affinity ultrafiltration mass spectrometry and the anti-inflammatory activity.
Zhang XY; Wei ZJ; Qiao WL; Sun XM; Jin ZL; Gong W; Jia BX
Fitoterapia; 2021 Jun; 151():104872. PubMed ID: 33657428
[TBL] [Abstract][Full Text] [Related]
23. Anticancer Potential of Dietary Natural Products: A Comprehensive Review.
Ahmad R; Khan MA; Srivastava AN; Gupta A; Srivastava A; Jafri TR; Siddiqui Z; Chaubey S; Khan T; Srivastava AK
Anticancer Agents Med Chem; 2020; 20(2):122-236. PubMed ID: 31749433
[TBL] [Abstract][Full Text] [Related]
24. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
[TBL] [Abstract][Full Text] [Related]
26. Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.
Hayashi S; Ueno N; Murase A; Nakagawa Y; Takada J
Eur J Med Chem; 2012 Apr; 50():179-95. PubMed ID: 22373734
[TBL] [Abstract][Full Text] [Related]
27. Exploiting cyclooxygenase-(in)dependent properties of COX-2 inhibitors for malignant glioma therapy.
Schönthal AH
Anticancer Agents Med Chem; 2010 Jul; 10(6):450-61. PubMed ID: 20879982
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies.
El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488
[TBL] [Abstract][Full Text] [Related]
29. Bioprospection of anti-inflammatory phytochemicals suggests rutaecarpine and quinine as promising 15-lipoxygenase inhibitors.
Gurung AB; Pamay P; Tripathy D; Biswas K; Chatterjee A; Joshi SR; Bhattacharjee A
J Cell Biochem; 2019 Aug; 120(8):13598-13613. PubMed ID: 30937959
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Novel 2-Amino-5-(Substituted)-1,3,4-Thiadiazole Derivatives: New Utilities for Colon Cancer Treatment.
Raj V; Rai A; Singh AK; Keshari AK; Trivedi P; Ghosh B; Kumar U; Kumar D; Saha S
Anticancer Agents Med Chem; 2018; 18(5):719-738. PubMed ID: 28425852
[TBL] [Abstract][Full Text] [Related]
31. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Lamie PF; Ali WAM; Bazgier V; Rárová L
Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
[TBL] [Abstract][Full Text] [Related]
32. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
33. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
34. 3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.
Rakesh KS; Jagadish S; Balaji KS; Zameer F; Swaroop TR; Mohan CD; Jayarama S; Rangappa KS
Inflammation; 2016 Feb; 39(1):269-280. PubMed ID: 26363638
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
[TBL] [Abstract][Full Text] [Related]
36. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
37. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
Bultum LE; Tolossa GB; Lee D
PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
[TBL] [Abstract][Full Text] [Related]
38. The industrial potential of herbs and spices - a mini review.
Leja KB; Czaczyk K
Acta Sci Pol Technol Aliment; 2016; 15(4):353-365. PubMed ID: 28071013
[TBL] [Abstract][Full Text] [Related]
39. Coumarins scaffolds as COX inhibitors.
Revankar HM; Bukhari SN; Kumar GB; Qin HL
Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
[TBL] [Abstract][Full Text] [Related]
40. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
